Yee, Elliott K.
Coburn, Natalie G.
Zuk, Victoria
Davis, Laura E.
Mahar, Alyson L.
Liu, Ying
Gupta, Vaibhav
Darling, Gail
Hallet, Julie
Funding for this research was provided by:
Canadian Institutes of Health Research Partnerships for Health System Improvement (154131)
Article History
Received: 11 October 2020
Accepted: 6 January 2021
First Online: 6 February 2021
Compliance with ethical standards
:
: Julie Hallet has received speaking honoraria from Ipsen Biopharmaceuticals Canada and Novartis Oncology. Natalie G. Coburn receives salary support from Cancer Care Ontario as the Clinical Lead for Patient Reported Outcomes.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. For the conduct of this retrospective population-based study, informed consent was waived by the Research Ethics Board of Sunnybrook Health Sciences Centre.
Free to read: This content has been made available to all.